Logo image of KLR

KALEYRA INC (KLR) Stock Fundamental Analysis

USA - NYSE:KLR - US4833792025 - Common Stock

7.24 USD
-0.01 (-0.14%)
Last: 10/4/2023, 8:18:07 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to KLR. KLR was compared to 282 industry peers in the Software industry. KLR may be in some trouble as it scores bad on both profitability and health. KLR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year KLR has reported negative net income.
In the past year KLR had a positive cash flow from operations.
KLR had negative earnings in each of the past 5 years.
In the past 5 years KLR reported 4 times negative operating cash flow.
KLR Yearly Net Income VS EBIT VS OCF VS FCFKLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of KLR (-26.04%) is worse than 68.68% of its industry peers.
KLR's Return On Equity of -335.78% is on the low side compared to the rest of the industry. KLR is outperformed by 85.41% of its industry peers.
Industry RankSector Rank
ROA -26.04%
ROE -335.78%
ROIC N/A
ROA(3y)-18.94%
ROA(5y)-12.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KLR Yearly ROA, ROE, ROICKLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 100 -100 200 -200 300

1.3 Margins

KLR has a worse Gross Margin (22.01%) than 84.70% of its industry peers.
The Profit Margin and Operating Margin are not available for KLR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KLR Yearly Profit, Operating, Gross MarginsKLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 10 -10 20 -20

1

2. Health

2.1 Basic Checks

KLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KLR has been increased compared to 1 year ago.
KLR has a worse debt/assets ratio than last year.
KLR Yearly Shares OutstandingKLR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M
KLR Yearly Total Debt VS Total AssetsKLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

KLR has an Altman-Z score of 0.20. This is a bad value and indicates that KLR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of KLR (0.20) is worse than 69.39% of its industry peers.
A Debt/Equity ratio of 7.81 is on the high side and indicates that KLR has dependencies on debt financing.
KLR's Debt to Equity ratio of 7.81 is on the low side compared to the rest of the industry. KLR is outperformed by 87.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.81
Debt/FCF N/A
Altman-Z 0.2
ROIC/WACCN/A
WACC8.07%
KLR Yearly LT Debt VS Equity VS FCFKLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

KLR has a Current Ratio of 1.39. This is a normal value and indicates that KLR is financially healthy and should not expect problems in meeting its short term obligations.
KLR has a Current ratio (1.39) which is comparable to the rest of the industry.
A Quick Ratio of 1.39 indicates that KLR should not have too much problems paying its short term obligations.
KLR has a Quick ratio (1.39) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39
KLR Yearly Current Assets VS Current LiabilitesKLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 50M 100M 150M

2

3. Growth

3.1 Past

KLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.76%.
KLR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.67%.
EPS 1Y (TTM)-111.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.24%
Revenue 1Y (TTM)3.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.96%

3.2 Future

KLR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.17% yearly.
The Revenue is expected to grow by 6.03% on average over the next years.
EPS Next Y73.88%
EPS Next 2Y40.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.51%
Revenue Next 2Y4.37%
Revenue Next 3Y6.03%
Revenue Next 5YN/A

3.3 Evolution

KLR Yearly Revenue VS EstimatesKLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
KLR Yearly EPS VS EstimatesKLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 0 5 -5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KLR. In the last year negative earnings were reported.
Also next year KLR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KLR Price Earnings VS Forward Price EarningsKLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KLR Per share dataKLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

KLR's earnings are expected to grow with 40.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KALEYRA INC

NYSE:KLR (10/4/2023, 8:18:07 PM)

7.24

-0.01 (-0.14%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2023-08-07/amc
Earnings (Next)11-06 2023-11-06/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.41%
Ins Owner Change0%
Market Cap96.51M
Analysts48
Price Target7.31 (0.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.53%
Min EPS beat(2)-17.79%
Max EPS beat(2)34.85%
EPS beat(4)1
Avg EPS beat(4)-548.61%
Min EPS beat(4)-2204.23%
Max EPS beat(4)34.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.96%
Min Revenue beat(2)4.96%
Max Revenue beat(2)4.96%
Revenue beat(4)3
Avg Revenue beat(4)3.46%
Min Revenue beat(4)-2.06%
Max Revenue beat(4)5.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-32.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)43.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF 16.26
P/B 3.66
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.84
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.45
OCFY6.15%
SpS26.1
BVpS1.98
TBVpS-10.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.04%
ROE -335.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.01%
FCFM N/A
ROA(3y)-18.94%
ROA(5y)-12.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 7.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.47%
Cap/Sales 2.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z 0.2
F-Score3
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)71.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.24%
EPS Next Y73.88%
EPS Next 2Y40.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.96%
Revenue Next Year4.51%
Revenue Next 2Y4.37%
Revenue Next 3Y6.03%
Revenue Next 5YN/A
EBIT growth 1Y23.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year165.4%
EBIT Next 3Y40.6%
EBIT Next 5YN/A
FCF growth 1Y87.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y128.25%
OCF growth 3YN/A
OCF growth 5YN/A